Dave was born prematurely and spent the first year of his life in the hospital, later diagnosed with hemophilia A at 15 months of age. Growing up in the southwest with his mother as single parent, Dave describes the biggest challenge of living with hemophilia A as just trying to be a kid and enjoy fun things. “I always wanted to play sports and be active — basketball, baseball, climbing, and bicycling. My Mom didn't like that I played so many sports and participated in other physical activities because it made me more susceptible to injury and it was hard to get me proper treatment.” Despite these challenges, Dave excelled in scholastics and graduated from National American University, earning a Bachelor of Science degree in Business Administration. “I was always a good student, interested in learning. That my Mom did like!”
Before switching to NUWIQ®, Dave was treated with an alternative infusion product, which he received for 10 years. However, he experienced troublesome side effects: rash and irritation as the product was infused. “It just made a hard process even harder and made me much less happy about infusing in general.” After many years of using the first–generation FVIII concentrate, Dave decided to explore other options. “It was time for a change. I wanted to see what else was available – and I did not want a FVIII product that was made from hamster cells.”
Dave did his research. He liked that NUWIQ was expressed in a human cell line with no chemical modifications. So, he made the switch. He worked with his doctor to create a personalized prophylaxis regimen, which only required 2 visits to his HTC for PK testing. “When I finally switched, I had many questions. How will this new product affect me? Will it be better for me? Will there be any side effects?”
“I was on my previous treatment 3 times per week. With NUWIQ, I was able to reduce it to twice per week. I feel like I'm able to do more even though I am infusing less.” Dave appreciates the convenience of NUWIQ when he travels, pointing out that NUWIQ is the only recombinant FVIII that offers 2.5 mL diluent volume across all vial sizes. Finally, Dave reports that with NUWIQ, he is getting the bleeding control he has been looking for.
“I would tell anyone who is thinking about switching their FVIII medication to consider NUWIQ. I'm very satisfied with how it works for me. It gets to the bleed fast, and I no longer have to deal with the rash and irritation when infusing. And everything you need is right there in the box: a pre–filled syringe with 2.5 mL diluent, a vial adapter, a butterfly needle, and even alcohol swabs!”
Today Dave continues his active lifestyle and enjoyment of physical activity, confident in his ability to manage any injuries with prophy or on–demand treatment with NUWIQ when needed. He enjoys his work in business and spending time with his wife and son.
This material represents individual patient and/or caregiver experience living with a bleeding disorder.
This content is not intended to be a substitute for professional medical advice, diagnosis or treatment. Please consult with your local Hemophilia Treatment Center physician or other health care provider if you have any questions related to management of bleeding disorders.
Este material representa la experiencia individual de un paciente o cuidador que vive con un trastorno hemorrágico
Este contenido no tiene como objetivo reemplazar el consejo, diagnóstico o tratamiento médico profesional. Consulte con el médico de su Centro de Tratamiento para la Hemofilia local u otro proveedor de atención médica si tiene preguntas relacionadas con el manejo de los trastornos hemorrágicos.